NTES [NetEase,] UPLOAD:
[]
MR [Mindray Medical International] 6-K: (Original Filing)
[Mindray Announces Second Quarter 2011 Financial Results Shenzhen, China August 8, 2011 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June 30, 2011. Highlights for Second Quarter 2011 Net revenues were $217.3 million, an increase of 21.2%]
MR [Mindray Medical International] 6-K: Mindray Announces Second Quarter 2011 Financial Results Shenzhen,
[Mindray Announces Second Quarter 2011 Financial Results Shenzhen, China August 8, 2011 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June 30, 2011. Highlights for Second Quarter 2011 Net revenues were $217.3 million, an increase of 21.2%]
MR [Mindray Medical International] SC 13G: (Original Filing)
[The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed but]
MR [Mindray Medical International] 6-K: (Original Filing)
[Mindray Announces Second Quarter 2011 Financial Results STYLE="font-family:Times New Roman" SIZE="2"> Shenzhen, China August8, 2011 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June30, 2011. Highlights for Second Quarter 2011 Net revenues were $217.3 million,]
MR [Mindray Medical International] 6-K: Mindray Announces Second Quarter 2011 Financial Results STYLE=”font-family:Times
[Mindray Announces Second Quarter 2011 Financial Results STYLE="font-family:Times New Roman" SIZE="2"> Shenzhen, China August8, 2011 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June30, 2011. Highlights for Second Quarter 2011 Net revenues were $217.3 million,]
MR [Mindray Medical International] SC 13G: (Original Filing)
[Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parentmpany Not Applicable Item 8. Identification and Classification of Members of the Not Applicable Item 9. Notice of Dissolution of Not Applicable Item 10. Certification By signing below I certify that, to the best of my knowledge and]
MR [Mindray Medical International] SC 13G: Item 7. Identification and Classification of the Subsidiary
[Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parentmpany Not Applicable Item 8. Identification and Classification of Members of the Not Applicable Item 9. Notice of Dissolution of Not Applicable Item 10. Certification By signing below I certify that, to the best of my knowledge and]
GRO [AGRIARP] SC 13G/A: (Original Filing)
[gro_3.txt 1 13G/A]
GRO [AGRIARP] SC 13G/A: gro_3.txt 1 13G/A
[gro_3.txt 1 13G/A]
